In vivo CTL induction with point-substituted ovalbumin peptides: immunogenicity correlates with peptide-induced MHC class I stability

By Lipford G.B.   Bauer S.   Wagner H.   Heeg K.  

Vaccine, Vol. 13, Iss. 3, 1995-01 ,pp. : 313-320

Elsevier

Access to resources Recommend Favorite

Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime

By Hanke T.   Blanchard T.J.   Schneider J.   Hannan C.M.   Becker M.   Gilbert S.C.   Hill A.V.S.   Smith G.L.   McMichael A.  

Vaccine, Vol. 16, Iss. 5, 1998-03 ,pp. : 439-445

Elsevier

Access to resources Recommend Favorite

Immunisation with modified HPV16 E7 genes against mouse oncogenic TC-1 cell sublines with downregulated expression of MHC class I molecules

By Smahel M.   Sma P.   Ludvkova V.   Marinov I.   Pokorna D.   Vonka V.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1125-1136

Elsevier

Access to resources Recommend Favorite

Bovine T cells preferentially recognize non-viral spacer epitopes in a putative FMDV vaccinal peptide

By Glass E.J.   Millar P.  

Vaccine, Vol. 13, Iss. 2, 1995-02 ,pp. : 225-229

Elsevier

Access to resources Recommend Favorite

Effect of adjuvant composition on immune response to a multiple antigen peptide (MAP) containing a protective epitope from Neisseria meningitidis class 1 porin

By Christodoulides M.   Rattue E.   Heckels J.E.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 131-139

Elsevier

Access to resources Recommend Favorite